doi: 10.1136/gut.2009.199661.
Epub 2010 Jul 21.
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications
Affiliations
- PMID: 20650925
- DOI: 10.1136/gut.2009.199661
Item in Clipboard
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications
Gut.
2010 Oct.
No abstract available
Similar articles
-
[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?].Gastroenterol Clin Biol. 2003 Oct;27(10):869-75. Gastroenterol Clin Biol. 2003. PMID: 14631300 Review. French. No abstract available.
-
NASH and HCC.Clin Liver Dis. 2009 Nov;13(4):631-47. doi: 10.1016/j.cld.2009.07.007. Clin Liver Dis. 2009. PMID: 19818310
-
Hepatocellular carcinoma and non-alcoholic fatty liver disease: Major liver diseases emerging from the Asia-Pacific Region.J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):6-7. doi: 10.1111/j.1440-1746.2005.04238.x. J Gastroenterol Hepatol. 2006. PMID: 16706801 No abstract available.
-
Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors?Am J Gastroenterol. 2010 Mar;105(3):632-4. doi: 10.1038/ajg.2009.715. Am J Gastroenterol. 2010. PMID: 20203644
-
Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: which clinical arguments?Ann Endocrinol (Paris). 2013 May;74(2):115-20. doi: 10.1016/j.ando.2013.02.008. Epub 2013 Apr 15. Ann Endocrinol (Paris). 2013. PMID: 23597944 Review.
Cited by
-
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators.Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):160-174. doi: 10.1038/s41575-018-0089-3. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30518830 Review.
-
Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we.World J Gastroenterol. 2019 Aug 7;25(29):3842-3848. doi: 10.3748/wjg.v25.i29.3842. World J Gastroenterol. 2019. PMID: 31413522 Free PMC article.
-
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics.Hepat Med. 2012 May 8;4:19-37. doi: 10.2147/HMER.S16316. Hepat Med. 2012. PMID: 24367230 Free PMC article. Review.
-
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.BMC Gastroenterol. 2021 Jul 31;21(1):306. doi: 10.1186/s12876-021-01884-5. BMC Gastroenterol. 2021. PMID: 34332532 Free PMC article.
-
Biological effects of corosolic acid as an anti-inflammatory, anti-metabolic syndrome and anti-neoplasic natural compound.Oncol Lett. 2021 Feb;21(2):84. doi: 10.3892/ol.2020.12345. Epub 2020 Dec 2. Oncol Lett. 2021. PMID: 33363621 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
